down arrow

Brooks Lab.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE650L01011
  • NSEID: BROOKS
  • BSEID: 533543
INR
126.50
1.65 (1.32%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 27.56 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

123.00127.75

52 Week

72.51202.80
Valuation
Technical
Day's Volume

CASH

27.56 k (-35.38%) Volume

Shareholding (Jan 2025)

FII

0.00%

Held by 1 FIIs

DII

9.90%

Held by 10 DIIs

Promoter

52.62%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%

  • Poor long term growth as Net Sales has grown by an annual rate of 7.52% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -4.65
2

Stock is technically in a Mildly Bearish range

3

With ROCE of 2.3, it has a Expensive valuation with a 5.6 Enterprise value to Capital Employed

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 373 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.14

stock-summary
Return on Equity

-33.54%

stock-summary
Price to Book

6.21

Revenue and Profits (1 Year):
Net Sales:
38 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-5 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-12.7%
0%
-12.7%
1 Year
19.07%
0%
19.07%
2 Years
93.39%
0%
93.39%
3 Years
32.36%
0%
32.36%
4 Years
73.28%
0%
73.28%
5 Years
558.71%
0%
558.71%

Brooks Lab. for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.52%
EBIT Growth (5y)
27.79%
EBIT to Interest (avg)
-4.65
Debt to EBITDA (avg)
3.82
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.78
Tax Ratio
0.15%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
9.90%
ROCE (avg)
-13.80%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
6.21
EV to EBIT
192.80
EV to EBITDA
93.52
EV to Capital Employed
5.58
EV to Sales
3.96
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.29%
ROE (Latest)
-33.54%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jan 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (9.9%)

FIIs

Held by 1 FIIs (0.0%)

Promoter with highest holding

Atul Ranchal (19.24%)

Highest Public shareholder

Quant Mutual Fund - Quant Business Cycle Fund (0%)

Individual Investors Holdings

32.13%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 84.94% vs 15.95% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -15.40% vs -64.32% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "38.45",
          "val2": "20.79",
          "chgp": "84.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.85",
          "val2": "1.51",
          "chgp": "22.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.45",
          "val2": "0.32",
          "chgp": "40.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.57",
          "val2": "-3.96",
          "chgp": "-15.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.81%",
          "val2": "7.26%",
          "chgp": "-2.45%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -3.22% vs 13.69% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -4.42% vs 47.24% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "38.73",
          "val2": "40.02",
          "chgp": "-3.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.79",
          "val2": "1.74",
          "chgp": "2.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.48",
          "val2": "0.36",
          "chgp": "33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.38",
          "val2": "-6.11",
          "chgp": "-4.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.62%",
          "val2": "4.35%",
          "chgp": "0.27%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 24.95% vs 22.32% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -9.61% vs 39.82% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "77.18",
          "val2": "61.77",
          "chgp": "24.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.64",
          "val2": "2.83",
          "chgp": "28.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.93",
          "val2": "0.57",
          "chgp": "63.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-10.95",
          "val2": "-9.99",
          "chgp": "-9.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.72%",
          "val2": "4.58%",
          "chgp": "0.14%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 25.78% vs -30.61% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 6.27% vs -29.09% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "79.49",
          "val2": "63.20",
          "chgp": "25.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.22",
          "val2": "-26.42",
          "chgp": "112.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.84",
          "val2": "2.18",
          "chgp": "-61.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.36",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-19.59",
          "val2": "-20.90",
          "chgp": "6.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.05%",
          "val2": "-41.80%",
          "chgp": "45.85%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
38.45
20.79
84.94%
Operating Profit (PBDIT) excl Other Income
1.85
1.51
22.52%
Interest
0.45
0.32
40.62%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-4.57
-3.96
-15.40%
Operating Profit Margin (Excl OI)
4.81%
7.26%
-2.45%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 84.94% vs 15.95% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -15.40% vs -64.32% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
38.73
40.02
-3.22%
Operating Profit (PBDIT) excl Other Income
1.79
1.74
2.87%
Interest
0.48
0.36
33.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-6.38
-6.11
-4.42%
Operating Profit Margin (Excl OI)
4.62%
4.35%
0.27%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -3.22% vs 13.69% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -4.42% vs 47.24% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
77.18
61.77
24.95%
Operating Profit (PBDIT) excl Other Income
3.64
2.83
28.62%
Interest
0.93
0.57
63.16%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-10.95
-9.99
-9.61%
Operating Profit Margin (Excl OI)
4.72%
4.58%
0.14%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 24.95% vs 22.32% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -9.61% vs 39.82% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
79.49
63.20
25.78%
Operating Profit (PBDIT) excl Other Income
3.22
-26.42
112.19%
Interest
0.84
2.18
-61.47%
Exceptional Items
0.00
0.36
-100.00%
Consolidate Net Profit
-19.59
-20.90
6.27%
Operating Profit Margin (Excl OI)
4.05%
-41.80%
45.85%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 25.78% vs -30.61% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 6.27% vs -29.09% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Brooks Laboratories Ltd stock-summary
stock-summary
Brooks Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Brooks Laboratories Limited was incorporated on January 23, 2002. The company was initially promoted for manufacturing latest molecules in Injectables, tablets and dry syrups for the domestic customers. Brooks Laboratories is a pharmaceutical manufacturing company working on contract basis. The company has manufacturing plants at Baddi, Himachal Pradesh and Vadodara, Gujarat. Both the units are cGMP compliant in conformity with national and international standards.
Company Coordinates stock-summary
Company Details
Village Kishanpura, Nilagarh Road Baddi Solan Himachal Pradesh : 174101
stock-summary
Tel: 91-1795-654001/02/03
stock-summary
http://www.brookslabs.net
stock-summary
investors@brookslabs.net
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."